NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING
February 15 2018 - 2:40AM
The shareholders of Active Biotech AB (publ) are invited to the
Extraordinary Shareholders' Meeting to be held on Monday 19 March
2018, at 5 pm at the company's offices, Scheelevägen 22 in Lund,
Sweden.
ENTITLEMENT TO
PARTICIPATE
Shareholders who wish to participate in the Meeting must (i) be
recorded in the register of shareholders maintained by Euroclear
Sweden AB on Tuesday 13 March 2018, and (ii) notify the company of
their intention to participate in the Meeting not later than on
Tuesday 13 March 2018.
Shareholders who have trustee-registered their shares must
re-register the shares in their own name to be entitled to
participate in the Meeting. Such registration, which may be
temporary, must be completed on Tuesday 13 March 2018. Accordingly,
shareholders must inform the trustee of this request in ample time
prior to this date.
There are a total of 96,824,320 shares and votes in Active Biotech.
The company holds no treasury shares.
NOTICE OF
PARTICIPATION
Notice of participation in the Meeting can be made in writing to
Active Biotech AB (publ), Attn: Susanne Jönsson, P.O. Box 724,
SE-220 07 Lund, Sweden, by telephone +46 (0)46-19 20 00 or by
e-mail to susanne.jonsson@activebiotech.com. The notice shall
include name, personal/corporate identity number, number of shares
held, daytime telephone number and, if applicable, the number of
advisors (not more than two) that will accompany the shareholder at
the Meeting.
Shareholders represented by proxy shall issue a dated and signed
power of attorney for the proxy. If the power of attorney is issued
on behalf of a legal entity, a certified copy of a registration
certificate or corresponding document shall be appended. The
original power of attorney and, where applicable, the certificate
should be submitted to the company at the address indicated above
well in advance of the Meeting. Proxy forms are provided at the
company's website, www.activebiotech.com, and sent to shareholders
that so request.
PROPOSED
AGENDA
-
Opening of the Meeting
-
Election of Chairman of the Meeting
-
Preparation and approval of the voting
list
-
Election of one or two persons to verify the
minutes
-
Approval of the agenda for the Meeting
-
Determination of whether the Meeting has been
duly convened
-
The Board of Director's proposal to issue new
shares
-
Closing of the Meeting
PROPOSED
RESOLUTIONS
New share issue
(item 7)
The Board of Directors proposes that the Meeting resolves to
increase the company's share capital with not more than SEK 250,000
through issue of not more than 48,412,160 new shares.
The shareholders of the company
shall be entitled to subscribe for the new shares with pre-emptive
rights, whereby two existing shares shall entitle to subscription
for one new share. Subscription can also be made without any
pre-emptive rights, as set forth in the complete issue
resolution.
The subscription price in the
rights issue shall be SEK 1 per share. The record date for the
right to participate in the rights issue shall be 26 March 2018.
Subscription for new shares shall be made during the period 28
March - 11 April 2018. The last day for trading in the Active
Biotech share including the right to participate in the rights
issue is 22 March 2018.
For further details and
information of background to and reasons for the rights issue,
refer to Active Biotech's press release on 15 February 2018.
___________________
DOCUMENTATION,
ETC.
Complete supporting documentation will be held available at the
company's offices, Scheelevägen 22 in Lund, Sweden, not later than
three weeks prior to the Meeting. Copies of the documentation will
be sent to shareholders who so request and provide their postal
address. Copies will also be distributed at the Meeting.
Shareholders are reminded of their
right to request information under Chapter 7, Section 32 of the
Swedish Companies Act.
Lund, Sweden, in February
2018
The Board of Directors of Active Biotech AB
(publ)
Notice of extraordinary
shareholders meeting
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Active Biotech via Globenewswire
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Apr 2023 to Apr 2024